These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37888390)

  • 21. Formulation and Evaluation of Thermoreversible In Situ Nasal Gels Containing Mometasone Furoate for Allergic Rhinitis.
    Altuntaş E; Yener G
    AAPS PharmSciTech; 2017 Oct; 18(7):2673-2682. PubMed ID: 28281209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and evaluation of novel in situ gels containing acyclovir for the treatment of oral herpes simplex virus infections.
    Chaudhary B; Verma S
    ScientificWorldJournal; 2014; 2014():280928. PubMed ID: 24790559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buspirone Hydrochloride Loaded In Situ Nanovesicular Gel as an Anxiolytic Nasal Drug Delivery System: In Vitro and Animal Studies.
    Abdelnabi DM; Abdallah MH; Elghamry HA
    AAPS PharmSciTech; 2019 Mar; 20(3):134. PubMed ID: 30830481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation on solution-to-gel characteristic of thermosensitive and mucoadhesive biopolymers for the development of moxifloxacin-loaded sustained release periodontal in situ gels.
    Sheshala R; Quah SY; Tan GC; Meka VS; Jnanendrappa N; Sahu PS
    Drug Deliv Transl Res; 2019 Apr; 9(2):434-443. PubMed ID: 29392681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and evaluation of
    A S; Ahmed MG; Gowda Bh J
    J Oral Biol Craniofac Res; 2021; 11(2):269-276. PubMed ID: 33717865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery.
    Teaima MH; El Mohamady AM; El-Nabarawi MA; Mohamed AI
    Drug Dev Ind Pharm; 2020 May; 46(5):751-761. PubMed ID: 32250181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.
    Cho HJ; Balakrishnan P; Park EK; Song KW; Hong SS; Jang TY; Kim KS; Chung SJ; Shim CK; Kim DD
    J Pharm Sci; 2011 Feb; 100(2):681-91. PubMed ID: 20803575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation and evaluation of periodontal in situ gel.
    Garala K; Joshi P; Shah M; Ramkishan A; Patel J
    Int J Pharm Investig; 2013 Jan; 3(1):29-41. PubMed ID: 23799203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(ethylene oxide/propylene oxide) copolymer thermo-reversible gelling system for the enhancement of intranasal zidovudine delivery to the brain.
    Ved PM; Kim K
    Int J Pharm; 2011 Jun; 411(1-2):1-9. PubMed ID: 21356294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cubosome-based thermosensitive
    Mohsen AM; Salama AAA; Asfour MH
    Pharm Dev Technol; 2023 Jul; 28(6):520-534. PubMed ID: 37213179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and evaluation of in situ nasal gel formulations of loratadine.
    Sherafudeen SP; Vasantha PV
    Res Pharm Sci; 2015; 10(6):466-76. PubMed ID: 26779266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pluronic lecithin organogel as a topical drug delivery system.
    Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A
    Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system.
    Gupta H; Jain S; Mathur R; Mishra P; Mishra AK; Velpandian T
    Drug Deliv; 2007 Nov; 14(8):507-15. PubMed ID: 18027180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimuli-Responsive in situ Spray Gel of Miconazole Nitrate for Vaginal Candidiasis.
    Hsin YK; Thangarajoo T; Choudhury H; Pandey M; Meng LW; Gorain B
    J Pharm Sci; 2023 Feb; 112(2):562-572. PubMed ID: 36096286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermoreversible Gel Formulation for the Intranasal Delivery of Salmon Calcitonin and Comparison Studies of
    Alparslan AL; Yıldız Türkyılmaz G; Kozacı LD; Karasulu E
    Turk J Pharm Sci; 2023 Jul; 20(3):127-140. PubMed ID: 37416996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statistical optimization of voriconazole nanoparticles loaded carboxymethyl chitosan-poloxamer based in situ gel for ocular delivery: In vitro, ex vivo, and toxicity assessment.
    Pardeshi SR; More MP; Patil PB; Mujumdar A; Naik JB
    Drug Deliv Transl Res; 2022 Dec; 12(12):3063-3082. PubMed ID: 35525868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thermoreversible Carbamazepine In Situ Gel for Intranasal Delivery: Development and In Vitro, Ex Vivo Evaluation.
    Mohananaidu K; Chatterjee B; Mohamed F; Mahmood S; Hamed Almurisi S
    AAPS PharmSciTech; 2022 Oct; 23(8):288. PubMed ID: 36271212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and Evaluation of
    Gurav NH; Husukale PS
    Turk J Pharm Sci; 2023 Jul; 20(3):185-197. PubMed ID: 37417201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation of Intranasal Mucoadhesive Thermotriggered In Situ Gel Containing Mirtazapine as an Antidepressant Drug.
    Ghazwani M; Vasudevan R; Kandasamy G; Manusri N; Devanandan P; Puvvada RC; Veeramani VP; Paulsamy P; Venkatesan K; Chidmabaram K; Dhurke R
    Gels; 2023 Jun; 9(6):. PubMed ID: 37367128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.